4//SEC Filing
Fiorino Anthony S. 4
Accession 0001144204-17-048544
CIK 0001208261other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 6:02 PM ET
Size
5.7 KB
Accession
0001144204-17-048544
Insider Transaction Report
Form 4
Fiorino Anthony S.
Chief Medical Officer and COO
Transactions
- Award
Stock Option
2017-09-14+90,000→ 90,000 totalExercise: $1.10From: 2017-09-14Exp: 2027-09-14→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]15% of the options shall vest ninety (90) days following the date of grant; 15% on the first-year anniversary of the date of grant (the "Anniversary") and 70% in equal portions at the end of each three (3) month period over the course of a two (2) year period commencing on the Anniversary.
Documents
Issuer
IMMUNE PHARMACEUTICALS INC
CIK 0001208261
Entity typeother
Related Parties
1- filerCIK 0001608901
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 6:02 PM ET
- Size
- 5.7 KB